Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
MicroIslet is a biotechnology company engaged in the development, and commercialization of patented technologies in the field of transplantation therapy for people with insulin-dependent diabetes. MicroIslet’s islet transplantation technology, including patented technology exclusively licensed from Duke University, includes methods for isolating, culturing, cryopreservation, and immuno-protection (microencapsulation) of islet cells. MicroIslet is working to develop and commercialize a first product, called MicroIslet-H(tm), a microencapsulated human islet cell suspension that will be used for transplantation in patients with insulin-dependent ( www.microislet.com )
MicroIslet , Inc.
6370 Nancy Ridge Drive Suite 112
San Diego, California 92121
USA
Tel: (858) 657-0287
Fax: (858) 657-0288